bid

Thursday, May 29, 2025

Google快讯 - lung cancer

Google
lung cancer
实时更新 2025年5月29日
新闻
The oral TKI sevabertinib has been granted priority review for use in patients harboring HER2 mutations in non-small cell lung cancer.
Facebook Twitter 标记为不相关
"The data clearly demonstrates SIL204's impact not just on pancreatic cancer, but also for colorectal and lung cancers, highlighting SIL204's ...
Facebook Twitter 标记为不相关
查看更多结果 | 修改此快讯
您收到此电子邮件是因为您订阅了Google快讯
RSS 以RSS Feed的形式接收此快讯
发送反馈

No comments:

Post a Comment

Google快讯 - home

home 实时更新 ⋅ 2025年12月18日 新闻 Obituary for Rebecca "Becky" (Neal) Kirkland | Ronald...